Trilogy Capital’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

Trilogy Capital’s Portfolio VCSH Stock Details VCSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$335K	Sell	4,242 -500	-11%	-$39.5K	0.01%	317
2026 Q1	$376K	Buy	4,742 +917	+24%	+$73.1K	0.02%	293
2025 Q4	$305K	Buy	3,825 +400	+12%	+$31.9K	0.01%	311
2025 Q3	$274K	Buy	3,425 +175	+5%	+$13.9K	0.01%	328
2025 Q2	$258K	Sell	3,250 -181	-5%	-$14.3K	0.01%	319
2025 Q1	$271K	Buy	+3,431	New	+$269K	0.01%	297
2023 Q2	–	Sell	-29,011	Closed	-$2.21M	–	272
2023 Q1	$2.21M	Buy	+29,011	New	+$2.2M	0.16%	90

Other funds holding VCSH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allstate Corporation Northbrook, Illinois $10B AUM 30.74% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NEPC LLC Boston, Massachusetts $5.36B AUM 7.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

Trilogy Capital's VCSH Position: Q2 2026 in Review

Trilogy Capital reduced its Vanguard Short-Term Corporate Bond ETF (VCSH) stake by 11% in Q2 2026, selling an estimated $39.5K and leaving 4,242 shares worth $335K. The position accounts for 0.01% of the portfolio, ranked #317.

Trilogy Capital first reported a position in VCSH in Q1 2023 and has held it in 7 quarters since. The position peaked at $2.21M in Q1 2023. 1,469 funds tracked by Wall St. Rank hold VCSH as of Q2 2026.

Trilogy Capital held 4,242 shares of Vanguard Short-Term Corporate Bond ETF worth $335K as of Q2 2026.
Trilogy Capital sold 500 Vanguard Short-Term Corporate Bond ETF shares in Q2 2026, an estimated $39.5K.
Vanguard Short-Term Corporate Bond ETF made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #317 holding.
Trilogy Capital first reported a position in Vanguard Short-Term Corporate Bond ETF in Q1 2023 and has held it in 7 quarters since.
Trilogy Capital's Vanguard Short-Term Corporate Bond ETF position peaked at $2.21M in Q1 2023.
1,469 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.